Genes linked to Alzheimer’s risk have been identified
Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
List view / Grid view
Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
A research team has developed a method for regenerating old brain stem cells from rat models, which could be used to treat age-related brain diseases.
A new technique called ‘ubiquitin clipping’ has been created which could aid proteomics research and the development of new drugs for ubiquitination.
A molecular switch that impacts immune responses to viral infections has been identified which could lead to better strategies to develop vaccines.
Researchers have discovered that removing the enzyme, PHLPP1, improves outcomes in a mouse model of sepsis so could be a potential drug target.
A new study has found that damage caused by Alzheimer's allows toxins to enter the brain, further harming neurons.
New research into sex-based differences of Parkinson's disease could lead to new treatments.
Researchers have discovered the mechanism behind the spread of Leishmania, indicating a potential drug target.
New findings show that the environment for pancreatic cancers plays a role in its metastasis, revealing a new potential drug target.
The cause and trigger of the large clumps of protein beta-amyloid found in the brains of early-stage Alzheimer's patients have been discovered.
A new study has revealed that glioblastomas contain four different types of cell which the researchers say should be treated separately.
Using a compound called PTC596 in combination with other drugs, researchers effectively treated pancreatic cancer in mice.
A chaperone protein has been identified as a possible therapeutic target for the treatment of Kennedy's disease and prostate cancer.
Researchers have identified a pathway in the immune system activated in Crohn's disease which could lead to investigating new treatments.
A study has found that signals from interferons can be blocked, allowing the immune system to attack tumours which provides a potential target.